Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts

Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Latest Articles

  • Open Access
    Exosomal B7H3 drives immunosuppression and serves as a biomarker for PD-1 blockage response in head and neck squamous cell carcinoma
    Wen Wang, Chulong Xie, Juncong Luo, Leru Kuang, Yihong Wu, Nini Li, Xiaoli Liu, Xiaoyu Feng, Zizi Li, Zhanyu Li, Hongyu Zhang, Jiaoping Mi and Qi Zeng
    Cancer Biology & Medicine July 2026, 20250835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0835
  • Open Access
    NSAIDs for PI3K-altered head and neck cancer: a biomarker-driven therapeutic opportunity
    Jovanka Gencel-Augusto, Daniel E. Johnson and Jennifer R. Grandis
    Cancer Biology & Medicine July 2026, 20260202; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0202
  • Open Access
    Cancer-immunity cycle-based molecular subtypes in breast cancer predict the response to immune checkpoint inhibitors
    Di Shao, Tianjian Yu, Yi Xiao and Zhiming Shao
    Cancer Biology & Medicine June 2026, 23 (6) 925-945; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0611
  • Open Access
    Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in advanced pancreatic ductal adenocarcinoma: a retrospective real-world analysis
    Yang Liu, Dandan Wu, Xing Li, Xihao Zhang, Rentao Li, Yanmei Ou, Hao Wang, Tongguo Si, Rui Xia, Yong Xu, Huikai Li, Chuntao Gao and Jihui Hao
    Cancer Biology & Medicine June 2026, 23 (6) 946-950; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0848
  • Open Access
    Chinese expert consensus on additional surgery following endoscopic resection for early colorectal cancer (2025 edition)
    Zhipeng Qi, Fuqiang Zhao, Xuhua Hu, Yunshi Zhong, Qian Liu, Zhongtao Zhang, Guiying Wang and Digestive Tract Polyp and Precancerous Lesion Professional Committee, China Anti-Cancer Association Colorectal Surgery Group, Society of Surgery, Chinese Medical Association Colorectal Group, Society of Digestive Endoscopy, Chinese Medical Association Surgical Group, Colorectal Tumor Committee, Chinese Medical Doctor Association
    Cancer Biology & Medicine June 2026, 23 (6) 796-809; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0784
  • Open Access
    Expansion of IL-2-independent tumor-infiltrating lymphocytes through a feeder-free process: a preclinical study for solid tumors
    Ying Zhang, Sicheng Du, Rongrui Liu, Chuanhua Zhao, Juan Li, Sisi Ye, Man Zhang, Xingming Ma, Zhou He, Wenjia Zhuang, Huajun Jin and Jianming Xu
    Cancer Biology & Medicine June 2026, 23 (6) 910-924; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0441
View more latest articles

Cover Story

Current issue

Cancer Biology & Medicine: 23 (6)
Cancer Biology & Medicine
Vol. 23, Issue 6
15 Jun 2026
  • Table of Contents
  • Index by author

Submit

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
Back to top

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire